Evaluation of 18F-FDG PET/CT for diagnosing cervical nodal metastases in patients with oral cavity or oropharynx carcinoma

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 108, Issue 6, 2009, Pages 933-938

  Piao, Yongnan ^a   Bold, Bayarkhuu ^a   Tayier, Abulajiang ^a   Ishida, Ryuji ^a   Omura, Ken ^a   Okada, Norihiko ^a   Shibuya, Hitoshi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; EVALUATION; FEMALE; HEAD AND NECK TUMOR; HUMAN; LYMPH NODE METASTASIS; MALE; METASTASIS; MIDDLE AGED; MOUTH TUMOR; NECK DISSECTION; OROPHARYNX TUMOR; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NECK DISSECTION; OROPHARYNGEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 71849086654     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2009.07.054     Document Type: Article

References (29)

1. Yii N.W., Patel P.H., Rhys-Evans P.H., and Breach N.M. Management of the N0 neck in early cancer of the oral tongue. Clin Otolaryngol 24 (1999) 75-79
2. Nakagawa T., Shibuya M., Yoshimura R., Miura M., Okada N., Kishimoto S., et al. Neck node metastasis after successful brachytherapy for early stage tongue carcinoma. Radiother Oncol 21 (1991) 100-106
3. Tankere F., Camproux A., Barry B., Guedon C., Depondt J., and Gehanno P. Prognostic value of lymph node involvement in oral cancers: a study of 137 cases. Laryngoscope 110 (2000) 2061-2065
4. Brockstein B., Haraf D.J., Rademaker A.W., et al. Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience. Ann Oncol 15 (2004) 1179-1186
5. Woolgar J.A., Rogers S.N., Lone D., Brown J.S., and Vaughan E.D. Cervical lymph node metastasis in oral cancer: the importance of even microscopic extracapsular spread. Oral Oncol 39 (2003) 130-137
6. Castelijns J.A., and van den Brekel M.W. Imaging of lymphadenopathy in the neck. Eur Radiol 12 (2002) 727-738
7. Robbins K.T., Clayman G., Levine P.A., Medina J., Sessions R., Shaha A., et al. Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. Arch Otolaryngol Head Neck Surg 128 (2002) 751-758
8. Ferlito A., Rinaldo A., Silver C.E., Gourin C.G., Shah J.P., Clayman G.L., et al. Elective and therapeutic selective neck dissection. Oral Oncol 42 (2006) 14-25
9. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. J Nucl Med 47 (2006) 755-762
10. Nahmias C., Carison E.R., Duncan L.D., Blodgett T.M., Kennedy J., Long M.J., et al. Positron emission tomography/computed tomography (PET/CT) scanning for preoperative staging of patients with oral/head and neck cancer. J Oral Maxillofac Surg 65 (2007) 2524-2535
11. Shah J.P., Strong E., Spiro R.H., and Vikram B. Surgical grand rounds. Neck dissection: current status and future possibilities. Clin Bull 11 (1981) 25-33
12. Som P.M., Curtin H.D., and Mancuso A.A. Imaging-based nodal classification for evaluation of neck metastatic adenopathy. AJR Am J Roentgenol 174 (2000) 837-844
13. Nieuwenhuis E.J., Castelijns J.A., Pijpers, van den Brekel M.W., Brakenhoff R.H., van der Waal I., et al. Wait-and-see policy for the N0 neck in early-stage oral and oropharyngeal squamous cell carcinoma using ultrasonography-guided cytology: is there a role for identification of the sentinel node?. Head Neck 24 (2002) 282-289
14. Curtin H.D., Ishwara H., Mancuso A.A., Dalley R.W., Caudry D.J., and McNeil B.J. Comparison of CT and MR imaging in staging of neck metastases. Radiology 207 (1998) 123-130
15. Akoǧlu E., Dutipek M., Bekiş R., Deǧirmenci B., Ada E., and Güneri A. Assessment methods in patients with head and neck squamous cell carcinoma. J Otolaryngol 34 (2005) 384-394
16. Hao S.P., and Ng S.H. Magnetic resonance imaging versus clinical palpation in evaluating cervical metastasis from head and neck cancer. Otolaryngol Head Neck Surg 123 (2000) 324-327
17. McGuirt W.F., Williams III D.W., Keyes Jr. J.W., Greven K.M., Watson Jr. N.E., Geisinger K.R., and Cappellari J.O. A comparative diagnostic study of head and neck nodal metastases using positron emission tomography. Laryngoscope 105 (1995) 373-375
18. Brouwer J., de Bree R., Comans E.F., Castelijns J.A., Hoekstra O.S., and Leemans C.R. Positron emission tomography using [18F] fluorodeoxyglucose (FDG-PET) in the clinically negative neck: Is it likely to be superior?. Eur Arch Otorhinolaryngol 261 (2004) 479-483
19. Hyde N.C., Prvulovich E., Newman L., Waddington W.A., Visvikis D., and Ell P. A new approach to pre-treatment assessment of the NO neck in oral squamous cell carcinoma: the role of sentinel node biopsy and positron emission tomography. Oral Oncol 39 (2003) 350-360
20. Ng S.H., Yen T.C., Liao C.T., Chang J.T., Chan S.C., Ko S.F., et al. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. J Nucl Med 46 (2005) 1136-1143
21. 18F] fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 20 (2002) 4199-4208
22. Stoeckli S.J., Steinert H., Pfalts M., and Schmid S. Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma. Head Neck 24 (2002) 345-349
23. Van den Brekel M.W., Stel H.V., Van der valk P., van der Waal I., Meyer C.J., and Snow G.B. Micrometastases from squamous cell carcinoma in neck dissection specimens. Eur Arch Otorhinolaryngol 249 (1992) 349-353
24. Ross G.L., Ross D.G., MacDonald D.G., Shoaib T., Camilleri I.G., and Robertson A.G. Improved staging of cervical metastases in clinically node-negative patients with head and neck squamous cell carcinoma. Ann Surg Oncol 11 (2004) 213-218
25. Civantos F.J., Gomez C., Duque C., Pedroso F., Goodwin W.J., Weed D.T., et al. Sentinel node biopsy in oral cavity cancer: correlation with PET scan and immunohistochemistry. Head Neck 25 (2003) 1-9
26. Wensing B.M., Vogel W.V., Marres H.A., Merkx M.A., Postema E.J., Oyen W.J., and van den Hoogen F.J. FDG-PET in the clinically negative neck in oral squamous cell carcinoma. Laryngoscope 116 (2006) 809-813
27. Van den Brekel M.W., van der Waal I., Meijer C.J., Freeman J.L., Castelijns J.A., and Snow G.B. The incidence of micrometastases in neck dissection specimens obtained from elective neck dissections. Laryngoscope 106 (1996) 987-991
28. Don D.M., Anzai Y., Lufkin R.B., Fu Y.S., and Calcaterra T.C. Evaluation of cervical lymph node metastases in squamous cell carcinoma of the head and neck. Laryngoscope 105 (1995) 669-674
29. Ogura I., Kurabayashi T., Amagasa T., and Sasaki T. Diagnostic accuracy of computed tomography for cervical metastases at different anatomical levels in carcinoma of the tongue. Dentomaxillofac Radiol 30 (2001) 246-248